Search research articles
Contact Us
Filters
Showing results (121-130 of 187) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2026
First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study
Jhanelle E Gray, Joel W Neal, Jyoti D Patel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 28, 2022
Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and Etoposide
Martin Reck, Tony S K Mok, Aaron Mansfield, et al.
JTO Clinical and Research Reports
|
September 9, 2022
Characterization of <i>MET</i> Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome Sequencing
So Yeon Kim, Jun Yin, Stephen Bohlman, et al.
Frontiers in Oncology
|
September 13, 2023
Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer
Robert Hsu, Denaly Chen, Bing Xia, et al.
JTO Clinical and Research Reports
|
September 25, 2024
Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b COSMIC-021 Study
Joel W Neal, Armando Santoro, Maria Gonzalez-Cao, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 5, 2015
Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma
Thomas M Paul, Stephen V Liu, Elise A Chong, et al.
Cancer Chemotherapy and Pharmacology
|
August 22, 2018
A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors
Stephen V Liu, Susan G Groshen, Karen Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2017
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
Joshua Bauml, Tanguy Y Seiwert, David G Pfister, et al.
Future Oncology (London, England)
|
February 13, 2024
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring <i>NRG1</i> gene fusions
Dong-Wan Kim, Alison M Schram, Antoine Hollebecque, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 5, 2025
50 years of Progress in Non-Small Cell Lung Cancer: A New Fellow's Guide in the Clinic
Jarushka Naidoo, Abesh Niroula, Dipesh Uprety, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 187) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2026
First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study
Jhanelle E Gray, Joel W Neal, Jyoti D Patel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 28, 2022
Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and Etoposide
Martin Reck, Tony S K Mok, Aaron Mansfield, et al.
JTO Clinical and Research Reports
|
September 9, 2022
Characterization of <i>MET</i> Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome Sequencing
So Yeon Kim, Jun Yin, Stephen Bohlman, et al.
Frontiers in Oncology
|
September 13, 2023
Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer
Robert Hsu, Denaly Chen, Bing Xia, et al.
JTO Clinical and Research Reports
|
September 25, 2024
Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b COSMIC-021 Study
Joel W Neal, Armando Santoro, Maria Gonzalez-Cao, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 5, 2015
Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma
Thomas M Paul, Stephen V Liu, Elise A Chong, et al.
Cancer Chemotherapy and Pharmacology
|
August 22, 2018
A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors
Stephen V Liu, Susan G Groshen, Karen Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2017
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
Joshua Bauml, Tanguy Y Seiwert, David G Pfister, et al.
Future Oncology (London, England)
|
February 13, 2024
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring <i>NRG1</i> gene fusions
Dong-Wan Kim, Alison M Schram, Antoine Hollebecque, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 5, 2025
50 years of Progress in Non-Small Cell Lung Cancer: A New Fellow's Guide in the Clinic
Jarushka Naidoo, Abesh Niroula, Dipesh Uprety, et al.
Page
of 19